Greater Houston Section

Fighting Cancer: Targeting CNS Malignancy with Kinase Inhibitors

  • 26 Jan 2017
  • 1:00 PM - 2:00 PM
  • Link sent from Online Registration

Fighting Cancer: Targeting CNS Malignancy with Kinase Inhibitors

January 26, 2016

Drug Design logo with the number 11

Delivering compounds to the brain can be difficult. Join us as Timothy P. Heffron begins our module on fighting cancer with a discussion on the unmet need for neurooncology treatments, the significant opportunities that remain for new kinase inhibitors in this space and the unique challenges and considerations for brain-penentrant kinase inhibitor programs.

Register Now!

What You Will Learn

  • Free brain penetration (as opposed to just brain penetration) must be considered by neurooncology programs
  • Kinase inhibitors are of interest for the treatment of both primary brain tumors and brain metastases.
  • Focused drug discovery efforts, including optimization of physicochemical properties, can yield freely brain penetrating kinase inhibitors

Webinar Details

  • Date: Thursday, January 26, 2017 @ 1 - 2pm CT
  • Fee: Free to Attend
  • Download Slides: Available Day of Broadcast


Powered by Wild Apricot Membership Software